JP2026004279A5 - - Google Patents
Info
- Publication number
- JP2026004279A5 JP2026004279A5 JP2025138126A JP2025138126A JP2026004279A5 JP 2026004279 A5 JP2026004279 A5 JP 2026004279A5 JP 2025138126 A JP2025138126 A JP 2025138126A JP 2025138126 A JP2025138126 A JP 2025138126A JP 2026004279 A5 JP2026004279 A5 JP 2026004279A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962908305P | 2019-09-30 | 2019-09-30 | |
| US62/908,305 | 2019-09-30 | ||
| JP2022519458A JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
| PCT/US2020/053258 WO2021067261A1 (en) | 2019-09-30 | 2020-09-29 | Knottin-immunostimulant conjugates and related compositions and methods |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519458A Division JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026004279A JP2026004279A (ja) | 2026-01-14 |
| JP2026004279A5 true JP2026004279A5 (enExample) | 2026-01-21 |
Family
ID=75337493
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519458A Pending JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
| JP2025138126A Pending JP2026004279A (ja) | 2019-09-30 | 2025-08-21 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519458A Pending JP2022549915A (ja) | 2019-09-30 | 2020-09-29 | ノッティン－免疫刺激剤複合体ならびに関連組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220257785A1 (enExample) |
| EP (1) | EP4037709A4 (enExample) |
| JP (2) | JP2022549915A (enExample) |
| KR (1) | KR20220071225A (enExample) |
| CN (1) | CN114585382A (enExample) |
| AU (1) | AU2020357806A1 (enExample) |
| CA (1) | CA3156165A1 (enExample) |
| WO (1) | WO2021067261A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019000071A2 (pt) | 2016-07-07 | 2019-07-02 | Bolt Biotherapeutics Inc | conjugados adjuvantes de anticorpo |
| CA3303472A1 (en) | 2018-04-13 | 2026-05-13 | Massachusetts Institute Of Technology | Brush prodrugs and uses thereof |
| EP3937984A1 (en) | 2019-03-15 | 2022-01-19 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| AU2020277470A1 (en) * | 2019-05-22 | 2022-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Drug conjugates and methods of using same |
| CA3154334A1 (en) * | 2019-10-16 | 2021-04-22 | Jeremiah A. Johnson | Brush prodrugs and uses thereof |
| AU2024379520A1 (en) * | 2023-11-16 | 2026-06-11 | Changping National Laboratory | N-oxide immune agonists activation by radiotherapy |
| WO2025193946A2 (en) * | 2024-03-14 | 2025-09-18 | Genentech, Inc. | Peptides binding lrrc15 and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2817197C (en) * | 2010-11-08 | 2020-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Fusion proteins comprising an engineered knottin peptide and uses thereof |
| US9587001B2 (en) * | 2012-10-19 | 2017-03-07 | The Board Of Trustees Of The Leland Stanford Junior University | Conjugated knottin mini-proteins containing non-natural amino acids |
| WO2014201245A1 (en) * | 2013-06-12 | 2014-12-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors |
| EP3180018B1 (en) * | 2014-08-12 | 2019-07-24 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2 and integrin-binding-fc-fusion protein |
| WO2017139570A1 (en) * | 2016-02-12 | 2017-08-17 | Massachusetts Intitute Of Technology | Synergistic tumor treatment with il-2, an integrin-binding-fc fusion protein, and a cancer vaccinne |
| US10765625B2 (en) * | 2016-03-15 | 2020-09-08 | The Board Of Trustees Of The Leland Stanford Junior University | Knottin-drug conjugates and methods of using the same |
| BR112019021520A2 (pt) * | 2017-04-14 | 2020-08-04 | Tollnine, Inc. | oligonucleotídeo, composto, polinucleotídeo imunomodulador, composição, conjugado, método para modular um receptor, método de tratamento de um tumor, método de tratamento de câncer, método para tratar um tumor, método de prevenção de câncer, método para induzir uma resposta imune |
| AU2020277470A1 (en) * | 2019-05-22 | 2022-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Drug conjugates and methods of using same |
| US20230211001A1 (en) * | 2020-07-30 | 2023-07-06 | The Board Of Trustees Of The Leland Stanford Junior University | Lysosomal Targeting Molecules Comprising Knottin Peptides And Related Compositions And Methods |
-
2020
- 2020-09-29 CA CA3156165A patent/CA3156165A1/en active Pending
- 2020-09-29 KR KR1020227013406A patent/KR20220071225A/ko active Pending
- 2020-09-29 AU AU2020357806A patent/AU2020357806A1/en active Pending
- 2020-09-29 US US17/762,694 patent/US20220257785A1/en active Pending
- 2020-09-29 CN CN202080072773.4A patent/CN114585382A/zh active Pending
- 2020-09-29 EP EP20870659.8A patent/EP4037709A4/en active Pending
- 2020-09-29 WO PCT/US2020/053258 patent/WO2021067261A1/en not_active Ceased
- 2020-09-29 JP JP2022519458A patent/JP2022549915A/ja active Pending
-
2025
- 2025-08-21 JP JP2025138126A patent/JP2026004279A/ja active Pending